|
Volumn 57, Issue 5-6, 2001, Pages 523-528
|
Psychotropic drug use in nursing homes - Diagnostic indications and variations between institutions
a a a a |
Author keywords
Antidepressants; Benzodiazepines; Neuroleptics; Nursing homes; Psychotropic drugs
|
Indexed keywords
ALIMEMAZINE;
ANTIDEPRESSANT AGENT;
ANTIHISTAMINIC AGENT;
ANXIOLYTIC AGENT;
BENZODIAZEPINE;
HYPNOTIC AGENT;
NEUROLEPTIC AGENT;
PROMETHAZINE;
PSYCHOTROPIC AGENT;
BENZODIAZEPINE DERIVATIVE;
CHLORPROMAZINE;
CHLORPROTHIXENE;
CLOZAPINE;
DIXYRAZINE;
FLUPENTIXOL;
HALOPERIDOL;
LEVOMEPROMAZINE;
MELPERONE;
PROCHLORPERAZINE;
RISPERIDONE;
SEDATIVE AGENT;
THIORIDAZINE;
ZUCLOPENTHIXOL;
AGE;
AGED;
ARTICLE;
DOCTOR PATIENT RELATION;
DRUG INDICATION;
DRUG USE;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MENTAL DISEASE;
NORWAY;
NURSING HOME;
PALLIATIVE THERAPY;
PREVALENCE;
PRIORITY JOURNAL;
SLEEP DISORDER;
ADULT;
CONTROLLED STUDY;
DRUG UTILIZATION;
LONG TERM CARE;
MEDICAL PRACTICE;
AGED;
AGED, 80 AND OVER;
ANXIETY;
CROSS-SECTIONAL STUDIES;
DATA COLLECTION;
DEPRESSION;
FEMALE;
HOMES FOR THE AGED;
HUMANS;
MALE;
MENTAL DISORDERS;
NORWAY;
NURSING HOMES;
PRESCRIPTIONS, DRUG;
PSYCHOMOTOR AGITATION;
PSYCHOTROPIC DRUGS;
SLEEP DISORDERS;
|
EID: 85017265899
PISSN: 00316970
EISSN: None
Source Type: Journal
DOI: 10.1007/s002280100348 Document Type: Article |
Times cited : (84)
|
References (32)
|